Healthcare Industry News: Criticare Systems
News Release - December 4, 2007
Criticare Announces the MEDRAD(R) Veris(R) MR Monitoring System is Approved for Marketing in JapanMILWAUKEE--(HSMN NewsFeed)--Criticare Systems, INC. (AMEX:CMD ). Criticare Systems, Inc. today announced that Criticare and MEDRAD, INC. received the last required approval by the Japanese Pharmaceutical and Medical Device Agency (PMDA) on November 26, 2007 to import and market the Veris MR Vital Signs Monitoring system in Japan. The Veris MR Monitor was jointly developed by Criticare and MEDRAD, is manufactured by Criticare, and will be marketed through an agreement with MEDRAD.
Bringing the Veris MR Monitor to the Japanese market is an important milestone for both Criticare and MEDRAD and represents an exciting opportunity for continued growth of the MR Patient Monitoring business.
Criticare (www.csiusa.com) designs, manufactures, and markets cost-effective patient monitoring systems and noninvasive sensors for a wide range of hospitals and alternate health care environments throughout the world.
This press release contains forward-looking statements. Such statements refer to the Company's beliefs and expectations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described. Such uncertainties include, but are not limited to, the timely completion of new products, regulatory approvals for new products, the risk of new and better technologies, risks relating to international markets, as well as general conditions and competition in the Company's markets. Other risks are set forth in Criticare's reports and documents filed from time to time with the Securities and Exchange Commission.
Source: Criticare Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.